David Abrams acquired 3.81 Million Nuvation Bio shares worth $9.99 Million. That's 0.31% of their equity portfolio (14th largest holding). The investor owns 1.78% of the outstanding Nuvation Bio stock. David Abrams acquired their 3.81 Million shares in Q1 2021. So far they never sold any shares in the company. The investor's estimated purchase price is $43.7 Million, resulting in a loss of 77%.